Connection

MUHAMMAD SOHAIL to Prosthesis-Related Infections

This is a "connection" page, showing publications MUHAMMAD SOHAIL has written about Prosthesis-Related Infections.
Connection Strength

14.517
  1. Bridging the Gap: From Early Recognition to Timely Referral for Cardiac Implantable Electronic Devices Infections. Am J Med. 2025 Dec; 138(12):1616-1624.
    View in: PubMed
    Score: 0.801
  2. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis. 2021 06 01; 72(11):1938-1943.
    View in: PubMed
    Score: 0.602
  3. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. JACC Clin Electrophysiol. 2021 01; 7(1):50-61.
    View in: PubMed
    Score: 0.577
  4. Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope. Pacing Clin Electrophysiol. 2020 03; 43(3):341-349.
    View in: PubMed
    Score: 0.552
  5. Infection Management. Card Electrophysiol Clin. 2018 12; 10(4):601-607.
    View in: PubMed
    Score: 0.506
  6. Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):735-740.
    View in: PubMed
    Score: 0.503
  7. Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0.491
  8. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018 05; 41(5):495-503.
    View in: PubMed
    Score: 0.482
  9. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 06; 26(3):958-970.
    View in: PubMed
    Score: 0.465
  10. Prevalence and antibiogram of methicillin resistant Staphylococcus aureus isolated from medical device-related infections; a retrospective study in Lahore, Pakistan. Rev Soc Bras Med Trop. 2017 Sep-Oct; 50(5):680-684.
    View in: PubMed
    Score: 0.464
  11. Strategies to prevent infections associated with cardiovascular implantable electronic devices. Expert Rev Med Devices. 2017 May; 14(5):371-381.
    View in: PubMed
    Score: 0.453
  12. Helcococcus kunzii prosthetic valve endocarditis secondary to lower extremity cellulitis. BMJ Case Rep. 2017 May 03; 2017.
    View in: PubMed
    Score: 0.453
  13. Management of bacteremia in patients living with cardiovascular implantable electronic devices. Heart Rhythm. 2016 11; 13(11):2247-2252.
    View in: PubMed
    Score: 0.432
  14. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 08; 9(8).
    View in: PubMed
    Score: 0.430
  15. Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia. Am J Med. 2016 Feb; 129(2):221.e11-20.
    View in: PubMed
    Score: 0.407
  16. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol. 2015 Apr 01; 115(7):912-7.
    View in: PubMed
    Score: 0.387
  17. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):137-44.
    View in: PubMed
    Score: 0.384
  18. Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol. 2014 Feb; 37(2):225-30.
    View in: PubMed
    Score: 0.352
  19. Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol. 2013 Nov 01; 112(9):1403-9.
    View in: PubMed
    Score: 0.351
  20. Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti Infect Ther. 2013 Feb; 11(2):201-10.
    View in: PubMed
    Score: 0.338
  21. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011 Nov 14; 171(20):1821-8.
    View in: PubMed
    Score: 0.307
  22. Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. Cleve Clin J Med. 2011 Aug; 78(8):529-37.
    View in: PubMed
    Score: 0.304
  23. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31(2):171-83.
    View in: PubMed
    Score: 0.296
  24. Contemporary management of cardiovascular implantable electronic device infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):831-9.
    View in: PubMed
    Score: 0.282
  25. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94.
    View in: PubMed
    Score: 0.257
  26. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
    View in: PubMed
    Score: 0.237
  27. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007 Jul 15; 45(2):166-73.
    View in: PubMed
    Score: 0.228
  28. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 08; 49(18):1851-9.
    View in: PubMed
    Score: 0.226
  29. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006 Feb; 119(2):147-54.
    View in: PubMed
    Score: 0.208
  30. Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis. Heart. 2020 12; 106(24):1878-1882.
    View in: PubMed
    Score: 0.143
  31. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 10; 42(10):1331-1339.
    View in: PubMed
    Score: 0.133
  32. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A?Population-Based Study. JACC Clin Electrophysiol. 2019 09; 5(9):1071-1080.
    View in: PubMed
    Score: 0.133
  33. Contemporary management of cardiac implantable electronic device infection. Heart. 2019 06; 105(12):961-965.
    View in: PubMed
    Score: 0.128
  34. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018 05; 41(5):524-531.
    View in: PubMed
    Score: 0.121
  35. Impact of Abandoned Leads on Cardiovascular Implantable Electronic?Device Infections: A?Propensity Matched Analysis of MEDIC (Multicenter?Electrophysiologic Device Infection?Cohort). JACC Clin Electrophysiol. 2018 02; 4(2):201-208.
    View in: PubMed
    Score: 0.118
  36. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50(1):117-124.
    View in: PubMed
    Score: 0.116
  37. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 01; 64(11):1516-1521.
    View in: PubMed
    Score: 0.114
  38. Antibacterial Envelope Is Associated With?Low Infection Rates After Implantable Cardioverter-Defibrillator and?Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol. 2017 10; 3(10):1158-1167.
    View in: PubMed
    Score: 0.114
  39. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.112
  40. Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves. Circ Arrhythm Electrophysiol. 2016 09; 9(9).
    View in: PubMed
    Score: 0.108
  41. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39(6):522-30.
    View in: PubMed
    Score: 0.106
  42. Role of PET Imaging in Management of Implantable Electronic Device Infection. JACC Cardiovasc Imaging. 2016 Mar; 9(3):291-3.
    View in: PubMed
    Score: 0.104
  43. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014 Jun; 7(6):541-9.
    View in: PubMed
    Score: 0.092
  44. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014 Aug; 37(8):955-62.
    View in: PubMed
    Score: 0.091
  45. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013 Nov; 57(10):1438-48.
    View in: PubMed
    Score: 0.088
  46. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111(6):874-9.
    View in: PubMed
    Score: 0.084
  47. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15(2):227-35.
    View in: PubMed
    Score: 0.082
  48. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9.
    View in: PubMed
    Score: 0.081
  49. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14; 59(7):681-7.
    View in: PubMed
    Score: 0.079
  50. Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012 Mar; 35(3):269-74.
    View in: PubMed
    Score: 0.078
  51. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8(11):1678-85.
    View in: PubMed
    Score: 0.075
  52. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34(4):450-9.
    View in: PubMed
    Score: 0.073
  53. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.072
  54. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):639-45.
    View in: PubMed
    Score: 0.072
  55. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13.
    View in: PubMed
    Score: 0.067
  56. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
    View in: PubMed
    Score: 0.056
  57. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6.
    View in: PubMed
    Score: 0.054
  58. Corynebacterium jeikeium prosthetic joint infection: case report and literature review. Scand J Infect Dis. 2005; 37(2):151-3.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.